Natalia Nekhotiaeva

Title: Innovations of Natalia Nekhotiaeva

Introduction

Natalia Nekhotiaeva is a prominent inventor based in Solna, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical conditions. With a total of two patents to her name, her work is recognized for its potential impact on healthcare.

Latest Patents

Her latest patents include "Quinoline derivatives and their use as tyrosine kinase inhibitors." This patent describes a compound of formula Quinoline derivatives and their use as tyrosine kinase inhibitors, as well as pharmaceutically acceptable salts thereof. The pharmaceutical composition developed by Nekhotiaeva contains a therapeutically effective amount of the compound, which is useful for treating cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema, or psoriasis.

Career Highlights

Nekhotiaeva's career is marked by her dedication to research and innovation in the pharmaceutical industry. She works at Clanotech AB, where she continues to explore new therapeutic avenues. Her work has the potential to change the landscape of treatment for several serious health conditions.

Collaborations

Some of her notable coworkers include Jacob Westman and Johan Wannberg, who contribute to her research efforts and collaborative projects.

Conclusion

Natalia Nekhotiaeva's innovative work in the field of pharmaceuticals showcases her commitment to advancing medical science. Her patents reflect her expertise and the potential for significant contributions to healthcare.